Public Health Emergency - Leading a Nation Prepared
BARDA uses an end-to-end strategy to prepare for the next influenza pandemic by supporting development, licensure, and manufacturing of better
products to detect, treat, and prevent seasonal and pandemic influenza. This strategy relies on the development of superior influenza diagnostics, treatments, and vaccines that can be rapidly manufactured.BARDA’s influenza medical countermeasure programs support
Aligned with the
HHS Pandemic Influenza Plan and
the National Influenza Vaccine Modernization Strategy, the Biomedical Advanced Research and Development Authority (BARDA) is moving the U.S. preparedness and response posture against influenza from a reactive to a proactive posture. Taking an integrated approach to pandemic influenza and emerging infectious disease preparedness enables BARDA to rapidly pivot to accelerate the development of new vaccines, therapeutic products, and diagnostic tests.BARDA is dedicated to supporting continued innovation and advancement in pandemic influenza preparedness. Detailed in the
National Influenza Vaccine Modernization Strategy, BARDA works with industry to expand domestic manufacturing capacity and advance the development of next generation influenza vaccines. ASPR also contributes through alternative vaccine delivery technology and vaccine adjuvant formulations, as well as the development and testing of novel influenza diagnostics and antiviral drugs.
By partnering with product developers and manufacturers, BARDA supports the development of cutting-edge influenza vaccines, diagnostics, and therapeutics. BARDA also maintains stockpiles of influenza vaccine antigens and adjuvants.
A strong domestic vaccine manufacturing capability is critical for national security and response to seasonal or pandemic flu. BARDA supports the expansion of the manufacturing capability of domestically manufactured vaccines, which is vital for effective pandemic response.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages